NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that its fourth quarter revenues rose 13 percent year over year, led by 23 percent growth in its diagnostics business.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.